This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Santolaya, M. E. Articles by Zubieta, M. Search for Related Content PubMed PubMed Citation Articles by Santolaya, M. E. Articles by Zubieta, M. Social Bookmarking                            What's this?

Early Hospital Discharge Followed by Outpatient Management Versus Continued Hospitalization of Children With Cancer, Fever, and Neutropenia at Low Risk for Invasive Bacterial Infection

From the Department of Pediatrics, Hospital Luis Calvo Mackenna; Department of Pediatrics, Hospital San Juan de Dios; Department of Pediatrics, Hospital San Borja Arriarán; Department of Pediatrics, Hospital Sótero del Río; Public Health Department and Microbiology Program, Faculty of Medicine, Universidad de Chile; Department of Pediatrics, Hospital Exequiel González Cortés; Department of Pediatrics, Hospital Roberto del Río, Santiago; and Infectious Diseases Subcommittee, National Chilean Program of Antineoplastic Drugs, Santiágo, Chile

Address reprint requests to María Elena Santolaya, MD, Department of Pediatrics, University of Chile, Los Huasos 1948, Las Condes, Santiago, Chile; e-mail: msantola{at}med.uchile.cl

PURPOSE: To compare outcome and cost of ambulatory versus hospitalized management among febrile neutropenic children at low risk for invasive bacterial infection (IBI).

PATIENTS AND METHODS: Children presenting with febrile neutropenia at six hospitals in Santiago, Chile, were categorized as high or low risk for IBI. Low-risk children were randomly assigned after 24 to 36 hours of hospitalization to receive ambulatory or hospitalized treatment and monitored until episode resolution. Outcome and cost were determined for each episode and compared between both groups using predefined definitions and questionnaires.

RESULTS: A total of 161 (41%) of 390 febrile neutropenic episodes evaluated from June 2000 to February 2003 were classified as low risk, of which 149 were randomly assigned to ambulatory (n = 78) or hospital-based (n = 71) treatment. In both groups, mean age (ambulatory management, 55 months; hospital-based management, 66 months), sex, and type of cancer were similar. Outcome was favorable in 74 (95%) of 78 ambulatory-treated children and 67 (94%) of 71 hospital-treated children (P = NS). Mean cost of an episode was US $638 (95% CI, $572 to $703) and US $903 (95% CI, $781 to $1,025) for the ambulatory and hospital-based groups, respectively (P = .003).

CONCLUSION: For children with febrile neutropenia at low risk for IBI, ambulatory management is safe and significantly cost saving compared with standard hospitalized therapy.

Supported by grant No. 1000680 FONDECYT.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R Phillips, R Skinner, and J C Chisholm Treating low-risk febrile neutropenia: Jenny's story Arch. Dis. Child., January 1, 2007; 92(1): 7 - 8. [Full Text] [PDF]

				C. O. Nijhuis, W. A. Kamps, S. M.G. Daenen, J. A. Gietema, W. T.A. van der Graaf, H. J.M. Groen, E. Vellenga, E. M. ten Vergert, K. M. Vermeulen, H. G. de Vries-Hospers, et al. Feasibility of Withholding Antibiotics in Selected Febrile Neutropenic Cancer Patients J. Clin. Oncol., October 20, 2005; 23(30): 7437 - 7444. [Abstract] [Full Text] [PDF]